Edward L. Murphy serves as Executive at Co-Diagnostics, Inc., where they oversee executive responsibilities. Since joining the company, Edward L. Murphy has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 23, 2025 involved receiving (via award) 57,499 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 23, 2025 | CODX | $0 | Award | 57,499 | $N/A | Discretionary |
Edward L. Murphy currently holds 281,666 shares of Co-Diagnostics, Inc. (CODX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward L. Murphy has been a net neutral trader of CODX stock. They have purchased $0 and sold $0 worth of shares.
Edward L. Murphy's most recent insider trade was on Nov 23, 2025, when they sold 57,499 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted